Filing Details
- Accession Number:
- 0001203311-19-000059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-20 18:41:44
- Reporting Period:
- 2019-11-18
- Accepted Time:
- 2019-11-20 18:41:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202794 | E Marc Lippman | 21823 30Th Drive Se Bothell WA 98021 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-18 | 17,500 | $19.02 | 148,813 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-18 | 17,500 | $116.17 | 131,313 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-11-18 | 17,500 | $12.76 | 148,813 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-18 | 17,500 | $115.43 | 131,313 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-11-18 | 17,500 | $0.00 | 17,500 | $12.76 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-11-18 | 17,500 | $0.00 | 17,500 | $19.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-05-21 | No | 4 | M | Direct | |
| 0 | 2021-05-19 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $115.89 to $116.61. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $115.06 to $115.89. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options were fully vested on 5/20/11.
- Options were fully vested on 5/20/12.
Billionaire Hedge Funds
